Graymatter Labs is a technology company.
Graymatter Labs has raised $1.0M across 1 funding round.
Graymatter Labs has raised $1.0M in total across 1 funding round.
Graymatter Labs has raised $1.0M in total across 1 funding round.
Graymatter Labs's investors include Lorie&co, Oak HC/FT, Pareto Holdings, StartHer, Venrex, Errol Damelin, Nitay Joffe.
Graymatter Labs is a cognitive wellness company that develops plant-based nootropic supplements designed to enhance mental focus, reduce stress, and improve cognitive stamina. Their flagship product, *Bright Mind*, is a natural daily supplement combining nootropics and adaptogens to boost productivity and mental clarity without causing crashes or anxiety. The product primarily serves individuals seeking to improve brain health and cognitive performance, addressing problems like mental fatigue, brain fog, and stress-related productivity loss. The company has gained traction by leveraging scientific research and personal entrepreneurial experience to create effective brain health solutions[2][3].
Founded by Jim Phillips, an entrepreneur who experienced burnout and sought natural ways to enhance cognition, Graymatter Labs emerged from a desire to provide healthier alternatives to stimulants like coffee. Collaborating with a PhD molecular biologist co-founder, they formulated *Bright Mind* to deliver sustained cognitive benefits. Early adoption and positive user feedback have helped the company build momentum in the growing nootropics market focused on brain health as a daily wellness ritual[2][3].
Graymatter Labs rides the rising trend of cognitive wellness and nootropics as consumers increasingly seek natural, science-backed ways to improve mental performance and manage stress. The timing aligns with growing awareness of brain health's importance in productivity and overall well-being. Market forces such as increased remote work, mental health focus, and demand for sustainable health products favor their growth. By making brain health accessible and feelable, Graymatter Labs contributes to normalizing cognitive supplements as part of daily wellness routines, influencing the broader health and wellness ecosystem[2][3].
Looking ahead, Graymatter Labs is positioned to expand its product line and deepen its scientific research base to capture more of the cognitive wellness market. Trends such as personalized nutrition, mental health integration, and biohacking could shape their journey. Their influence may grow as brain health becomes a mainstream daily priority, potentially leading to partnerships with health platforms or workplace wellness programs. Their authentic origin story and science-driven approach provide a strong foundation for sustained impact in the evolving nootropics and wellness space[2][3].
Graymatter Labs has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2025 | $1.0M Seed | Lorie&co, Oak HC/FT, Pareto Holdings, StartHer, Venrex, Errol Damelin, Nitay Joffe |